HSIC vs ISPC · P/E 24, rev $12.67B vs rev $9.3M
Henry Schein Inc (HSIC) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the HSIC and ISPC stock pages for the full models.
Not investment advice.